Latest Research

Latest impactful research news stories in the biobanking field. Share Your Research

EU-CardioRNA COST Action Meetings Report Released

The European Cooperation in Science and Technology (COST Association) runs an EU-funded programme that encourages researchers and innovators to create research networks called COST Actions. The EU-CardioRNA COST Action, launched in 2018, is intended to promote transcriptomics research in...
metabolomics needs biobanks

Biobanking Science: Metabolomics Biobanks

Metabolomics, an important part of precision medicine, is the study of different metabolites in normal and disease states. Collecting, processing and storing samples for metabolomics studies presents unique challenges for biobanks. Metabolites are small (low molecular weight) and unstable molecules....

Complement And Coagulation Disorders Associated With COVID-19

Recent structure based comparisons suggest that coronavirus proteins mimic at least 140 human proteins, including those in the complement and coagulation pathways. The complement cascade leading to cell death and inflammation is part of the innate immune system, and...
Chemosensitizers may help fight antibiotic resistance.

Biobanking Science: Tackling Antibiotic Resistance

Antibiotic resistance is a major health issue. More than 700,000 people around the world die from antibiotic-resistant bacterial infections every year—23,000 of those are in the United States (1). If we don’t find a solution, the number of deaths...

Learning From Human Bile – A Machine Intelligence Approach

The digestive fluid called bile is made up of acids, salts, fats, and the pigment bilirubin, stored and concentrated in the gall bladder, and produced by the liver. Protein is a significant component of bile, 5% of the dry...

Thousands of Undiagnosed Cases of Type 2 Diabetes Identified by Screening UK Biobank Blood...

A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes. The study, presented at this year's Annual Meeting of the European Association for the Study of Diabetes...

PALB2 May Be A Risk Locus For Ovarian Cancer

According to US Surveillance, Epidemiology, and End Results (SEER), overall, the five year survival rate for ovarian cancer is 49%, however for those aged 15-39 the survival rate is 81% and declines steadily with age; 65-74 year olds having...

Estrogen Receptor Isoforms Are Down-Regulated In Hepatocellular Carcinoma

Estrogen receptor alpha (ERα) translocates to the nucleus and induces gene expression upon activation. The estrogen receptor is a target of US Food and Drug Administration FDA approved drugs such as the selective estrogen receptor degrader called Fulvestrant, which...

Colorectal Cancer: A Biobank of Patient-derived Xenografts

According to GLOBOCAN 2018 data, colorectal cancer (CRC) is the third most deadly and fourth most commonly diagnosed cancer in the world. There were nearly 2 million new cases and about 1 million deaths in 2018. The incidence of...

Biomarker Changes In Skin Keratinocytes Responsive To Blood Glucose

Biomarkers in the skin can reflect disease status in conditions as diverse as diabetes,  rheumatism, lung disease, and neurodegenerative diseases. In the case of diabetes, minimally invasive skin mounted glucose monitoring devices exist. Each device has its pros and...

🔥 Most Popular



Featured Vendors
X